Skip to main content
. 2020 Jan 21;13:657–666. doi: 10.2147/OTT.S223321

Figure 6.

Figure 6

SNHG15 knockdown enhances cisplatin sensitivity in tumors in vivo. (A) Tumor growth curves of xenograft tumors of mice inoculated with MCF-7/DDP cells stably expressing sh-SNHG15 or si-con and treated with cisplatin or PBS. (B) Images and weight analysis of xenograft tumors. (C) Expression levels of SNHG15 and miR-381 in xenograft tumors were quantified by qRT-PCR. *P<0.05.